GLP-1 drugs may cause scurvy in patients

Loading... 408 view(s) 7 min read

GLP-1 medications such as Ozempic, Wegovy, and Mounjaro have become widely used treatments for obesity and type 2 diabetes. These medications work by mimicking a hormone that helps regulate appetite and blood sugar levels, often leading to significant weight loss.

However, recent reports and research discussions have raised an unexpected question: could these medications contribute to nutrient deficiencies such as scurvy?

Scurvy is a disease caused by severe vitamin C deficiency, historically associated with sailors who lacked access to fresh fruits and vegetables. While the condition is rare in modern developed countries, experts have begun discussing whether the appetite-suppressing effects of GLP-1 drugs could indirectly increase the risk in some patients.

This article explains:

What scurvy is and why it happens
Why GLP-1 medications may increase nutritional risks in some people
How to prevent nutrient deficiencies while using weight-loss medications
Why medical supervision is essential when using GLP-1 therapy

Can GLP-1 Drugs Actually Cause Scurvy?

The short answer is not directly.

GLP-1 receptor agonists do not cause vitamin C deficiency themselves. Instead, the potential risk comes from the way these medications affect eating habits.

These drugs work by:

Slowing stomach emptying
Reducing appetite
Increasing feelings of fullness
Decreasing overall calorie intake

For many patients, this leads to weight loss. However, if food intake drops too low — especially if meals lack fruits and vegetables — vitamin intake can also decline.

Because the human body cannot produce vitamin C, it must be obtained from food sources such as:

Citrus fruits
Berries
Capsicum
Broccoli
Leafy greens

If intake of these foods becomes extremely low for several weeks, vitamin C stores can become depleted, potentially leading to scurvy.

Why Scurvy Is Being Discussed in GLP-1 Users

Although scurvy is rare today, it can develop when vitamin C intake is very low for four to twelve weeks.

Researchers and clinicians have highlighted several reasons why some GLP-1 users may face nutritional risks:

1. Dramatically reduced appetite

Many patients report eating far less while taking GLP-1 medications.

2. Nausea and gastrointestinal side effects

Common side effects include:

nausea
vomiting
reduced desire to eat

These symptoms can make balanced eating difficult.

3. Very restrictive diets

Some patients consume extremely small meals focused mainly on protein or meal replacements.

4. Lack of nutritional monitoring

Many clinical trials focused primarily on weight loss rather than nutritional adequacy.

A review of GLP-1 trials involving over 50,000 participants found that very few studies carefully monitored patients’ diets or micronutrient intake.

Symptoms of Scurvy Patients Should Know

Scurvy develops slowly and can initially resemble other conditions.

Early symptoms may include:

fatigue
irritability
weakness
joint pain

As deficiency worsens, symptoms may include:

bleeding gums
easy bruising
poor wound healing
swollen joints
anemia

These symptoms occur because vitamin C is essential for collagen production, which helps maintain healthy skin, blood vessels, and connective tissues.

Practical Implications for Patients Using GLP-1 Medications

For most patients, the benefits of GLP-1 medications can be significant. They are among the most effective medical treatments currently available for obesity and type 2 diabetes.

However, experts emphasise that weight loss should not come at the cost of nutritional health.

Patients using these medications should consider the following:

Maintain a nutrient-dense diet

Even when appetite is low, focus on foods that provide essential nutrients.

Key foods include:

citrus fruits
berries
vegetables
lean protein
whole grains

Avoid extremely restrictive eating

Eating too little overall can increase the risk of vitamin deficiencies.

Work with healthcare professionals

Medical supervision helps ensure weight loss occurs safely.

Consider dietitian support

Dietitians can help patients maintain adequate nutrition while losing weight.

Medical Supervision and Responsible GLP-1 Treatment

GLP-1 medications should always be prescribed and monitored by qualified healthcare professionals.

Proper clinical care typically includes:

assessment of medical history
monitoring of weight loss progress
evaluation of side effects
guidance on nutrition and lifestyle

This approach ensures patients receive balanced, evidence-based care, rather than relying solely on medication.

Importantly, experts stress that reports of scurvy do not mean GLP-1 drugs are unsafe. Instead, they highlight the importance of maintaining adequate nutrition while using these powerful medications.

Final Thoughts

GLP-1 medications represent a major advancement in the treatment of obesity and metabolic disease. For many patients, they provide meaningful health improvements and long-term weight management.

However, like any medical treatment, they require careful use and appropriate medical guidance.

Current evidence suggests that GLP-1 drugs do not directly cause scurvy, but their appetite-suppressing effects may increase the risk of vitamin deficiencies if patients significantly reduce their food intake without maintaining a balanced diet.

The key message for patients is simple:

Weight loss medications work best when combined with proper nutrition, professional medical supervision, and sustainable lifestyle changes.

FAQ

Can Ozempic or Wegovy directly cause scurvy?

No. These medications do not directly cause vitamin C deficiency. However, their appetite-suppressing effects may reduce food intake enough to increase the risk of nutrient deficiencies in some patients.

How long does it take for scurvy to develop?

Scurvy can develop after 4–12 weeks of extremely low vitamin C intake, especially if fruits and vegetables are absent from the diet.

What foods prevent scurvy?

Foods rich in vitamin C include:

oranges and citrus fruits
strawberries
capsicum
broccoli
tomatoes
leafy greens

Should patients stop GLP-1 medication because of scurvy risk?

No. Patients should not stop medications without consulting their doctor. Instead, they should focus on maintaining a balanced diet and discussing any symptoms with a healthcare professional.